Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019
October 23, 2019 at 05:46 am
Share
Harbin Medisan Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 1,631.127 million compared to CNY 1,575.590 million a year ago. Operating income was CNY 200.283 million compared to CNY 228.071 million a year ago. Net income was CNY 150.760 million compared to CNY 181.739 million a year ago. Basic earnings per share from continuing operations was CNY 0.48 compared to CNY 0.57 a year ago.
HARBIN MEDISAN PHARMACEUTICAL CO LTD is a China-based company principally engaged in the research and development, production and sales of chemical preparations, active pharmaceutical ingredients (APIs), medical devices and cosmetics. Its medicines cover the nervous system, cardio-cerebrovascular, systemic anti-infection, musculoskeletal, nutritional infusion, and body fluid balance infusion therapeutic fields. The Company's products include freeze-dried powder injections, small volume injections, large infusion products, solid preparations, medical devices and cosmetics. The Company mainly distributes its products within domestic market.
HARBIN MEDISAN PHARMACEUTICAL CO., LTD. 
